Announcements Trials

Browse Landscape

Phase

Phase 2 4 Phase 1 4 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 18 Carcinoma, Non-Small-Cell Lung 10 Carcinoma, Renal Cell 9 Kidney Neoplasms 4 Stomach Neoplasms 3 Mesothelioma 3 Lung Neoplasms 3 Diabetes Mellitus, Insulin-Dependent, 12 3 Carcinoma, Hepatocellular 3 Skin Neoplasms 2 Prostatic Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasm Metastasis 2 Mesothelioma, Malignant 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Various Advanced Cancer 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Recurrent Squamous Cell Lung Carcinoma 1 Recurrence 1 Non-Small Cell Lung Cancer Metastatic 1 Neoplasms 1 Melanoma, Cutaneous Malignant 1 Lymphatic Metastasis 1

Interventions

Fluorouracil 72 Leucovorin 71 Oxaliplatin 47 Irinotecan 31 Capecitabine 24 Bevacizumab 23 Folfox protocol 20 Cetuximab 15 Chemotherapy, Adjuvant 13 Celecoxib 7 Aspirin 6 Laparoscopy 5 XELOX 4 Panitumumab 4 Neoadjuvant Therapy 4 Levamisole 4 dehydroftorafur 3 Tegafur 3 Surgical Procedures, Operative 3 Observation 3 Floxuridine 3 vatalanib 2 tislelizumab 2 pertuzumab 2 encorafenib 2 atezolizumab 2 Trastuzumab 2 Standard of Care 2 Semaxinib 2 Selenium 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colonic Neoplasms × Ipilimumab × Clear all

NCT06490536 2025-08-29

The Sagittarius Trial

IFOM ETS - The AIRC Institute of Molecular Oncology

Phase 3 Recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡